Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Jawbone says Fitbit is no longer seeking to block sales of its products

Of course, Jawbone isn’t selling that many fitness trackers these days either.

Jawbone Health CEO Hosain Rahman
Jawbone Health CEO Hosain Rahman
Jawbone CEO Hosain Rahman
Jawbone

Jawbone said Saturday that one part of its legal battle with Fitbit has been resolved.

In a statement to Recode, Jawbone said Fitbit is no longer seeking to block the import of its products. Fitbit had filed a complaint against Jawbone with the U.S. International Trade Commission, a government organization that has the power to stop products from being brought into the country.

“Fitbit has moved to drop its patent case against Jawbone, which had been set for trial in the International Trade Commission in March,” Jawbone said in a statement. “By dismissing this action, Fitbit is no longer seeking to block importation of Jawbone devices, including Jawbone products in development.”

In terminating the ITC case, Fitbit said that Jawbone was in dubious financial shape and no longer selling the fitness products at issue.

“Press reports and other public documents indicate that the demise of Jawbone’s products has created substantial questions regarding Jawbone’s ability to continue to operate,” Fitbit said in this week’s filing.

Fitbit declined to comment beyond the filing.

The case had been losing steam as Jawbone has been pulling back on its fitness tracker products, while some of Fitbit’s patents were invalidated.

Jawbone says it will continue with its own, separate case against Fitbit, which alleges former workers took trade secrets to Fitbit.

Here is Jawbone’s full statement:

“Fitbit has moved to drop its patent case against Jawbone, which had been set for trial in the International Trade Commission in March. By dismissing this action, Fitbit is no longer seeking to block importation of Jawbone devices, including Jawbone products in development. Jawbone believes this case -- involving patents already found once to be invalid -- should have been dismissed long ago by Fitbit. Fitbit’s pursuit of these baseless claims for so long was to burden Jawbone-- an issue to be raised in Jawbone’s antitrust claim against Fitbit. Jawbone’s trade secret case in California state court against Fitbit will move forward to a jury trial in 2017.”

Update: Story updated to include comments from Fitbit’s filing with the U.S. International Trade Commission.


This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh